In breast cancer, DPYSL3 knockdown determined a reduced proliferation, but a still enhanced motility and increased expression of epithelial-to-mesenchymal transition markers, suggesting that DPYSL3 is a multifunctional signaling modulator. The gene discussed is DPYSL3; the disease is breast cancer.